Diagnostics company sphingotec has secured 5 million funding from Brandenburg Kapital, a subsidiary of ILB, and a Swiss family office
Innovative biomarkers for predicting and monitoring of life-threatening situations in intensive care patients
Innovative biomarkers for predicting and monitoring of life-threatening situations in intensive care patients